Industry Attorneys Ask FDA to Narrow Off-Label Communications Guidance

Drug Industry Daily
A A
Recent action from a state legislature, as well as objections from industry groups, suggest the FDA should narrow its guidance for off-label claims, according to two prominent labeling attorneys.

To View This Article:

Login

Subscribe To Drug Industry Daily